Neuronal injury and neuroprotection

被引:3
|
作者
Menon, David K. [1 ,2 ]
Wheeler, Daniel W. [1 ]
机构
[1] Univ Cambridge, Anaesthesia, Cambridge, England
[2] Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England
来源
关键词
agents; brain; hypoxia; injury; ischaemia; neuroprotective; neurosurgery; stroke; trauma;
D O I
10.1383/anes.6.6.184.65786
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Cerebral ischaemia is responsible for many deaths and causes an enormous amount of disability. Neurons are particularly susceptible to ischaemic injury because of their high metabolic rate and associated oxygen and energy requirements, and because brain repair mechanisms in humans appear to be absent or very limited. Primary neuronal injury may result from focal or global ischaemia, or traumatic brain injury. After injury, chains of physiological and pathophysiological events occur (e.g. inflammation) that cause secondary brain injury. This article describes these processes, and the efforts that have been made to intervene to improve outcome after cerebral ischaemia. Although the benefit of optimizing oxygenation and controlling intracranial pressure are beyond doubt, many potentially neuroprotective compounds that have been studied have been unsuccessful, despite promising results in experimental animal models. The authors discuss the reasons why this may be, and the growing realization that not all the processes previously thought to cause secondary injury are deleterious after all, and that a subtle interplay between them may offer some degree of neuroprotection or even brain repair. © 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:184 / 188
页数:5
相关论文
共 50 条
  • [1] New Mechanisms of Neuronal Injury and Neuroprotection
    Ying, Weihai
    CURRENT DRUG TARGETS, 2012, 13 (02) : 157 - 158
  • [2] Clinical neuroprotection and secondary neuronal injury mechanisms
    Knowlden, Peter
    Hunt, Katherine
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2008, 9 (05): : 184 - 186
  • [3] Clinical neuroprotection and secondary neuronal injury mechanisms
    Waraich, Manni
    Ajayan, Neeraja
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2024, 25 (01): : 16 - 22
  • [4] Clinical neuroprotection and secondary neuronal injury mechanisms
    Hayward, Elizabeth
    Hunt, Katharine
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2011, 12 (05): : 198 - 200
  • [5] Clinical neuroprotection and secondary neuronal injury mechanisms
    Hunt, Katharine
    Virmani, Surbhi
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2014, 15 (04): : 168 - 170
  • [6] Clinical neuroprotection and secondary neuronal injury mechanisms
    Hunt, Katharine
    Bose, Gahan
    ANAESTHESIA AND INTENSIVE CARE MEDICINE, 2020, 21 (06): : 293 - 297
  • [7] Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury
    Jawad, Noorulhuda
    Rizvi, Maleeha
    Gua, Jianteng
    Adeyi, Olar
    Tao, Guocai
    Maze, Mervyn
    Ma, Daqing
    NEUROSCIENCE LETTERS, 2009, 460 (03) : 232 - 236
  • [8] SPECTRIN PROTEOLYSIS IN THE HIPPOCAMPUS - A BIOCHEMICAL MARKER FOR NEURONAL INJURY AND NEUROPROTECTION
    ROBERTSLEWIS, JM
    SIMAN, R
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 679 : 78 - 86
  • [9] Astrocytic-neuronal crosstalk: Implications for neuroprotection from brain injury
    Barreto, George E.
    Gonzalez, Janneth
    Torres, Yolima
    Morales, L.
    NEUROSCIENCE RESEARCH, 2011, 71 (02) : 107 - 113
  • [10] Neuronal death after peripheral nerve injury and experimental strategies for neuroprotection
    Hart, Andrew M.
    Terenghi, Giorgio
    Wiberg, Mikael
    NEUROLOGICAL RESEARCH, 2008, 30 (10) : 999 - 1011